Allscripts (MDRX) Reports In-Line Q2 EPS
Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $428 million versus the consensus estimate of $425 million.
For earnings history and earnings-related data on Allscripts (MDRX) click here.
